MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
2.355
-0.075 (-3.09%)
At close: May 9, 2025, 4:00 PM
2.370
+0.015 (0.64%)
After-hours: May 9, 2025, 7:06 PM EDT
MaxCyte Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for MaxCyte stock has a target of 9.00, which predicts a 282.17% increase from the current stock price of 2.36.
Price Target: $9.00 (+282.17%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 12, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for MaxCyte is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +282.17% | Mar 12, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +367.09% | Apr 23, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +367.09% | Mar 13, 2024 |
| BTIG | BTIG | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +239.70% | Mar 13, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +197.24% | Nov 29, 2023 |
Financial Forecast
Revenue This Year
42.12M
from 38.63M
Increased by 9.05%
Revenue Next Year
50.54M
from 42.12M
Increased by 19.98%
EPS This Year
-0.36
from -0.39
EPS Next Year
-0.31
from -0.36
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 44.2M | 54.4M | 93.3M | ||
| Avg | 42.1M | 50.5M | 90.6M | ||
| Low | 39.5M | 46.1M | 87.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.4% | 29.1% | 84.6% | ||
| Avg | 9.1% | 20.0% | 79.4% | ||
| Low | 2.2% | 9.3% | 72.3% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.35 | -0.30 |
| Avg | -0.36 | -0.31 |
| Low | -0.40 | -0.34 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.